Disease Info Card

Pituitary Tumor Transforming Gene Overexpression

Information about Pituitary Tumor Transforming Gene Overexpression: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pituitary Tumor Transforming Gene Overexpression

Most recent studies have shown that Pituitary Tumor Transforming Gene Overexpression shares some biological mechanisms with adenocarcinoma, adenoma, carcinoma, cell-invasion, cell-transformation-neoplastic, colorectal-cancer, colorectal-neoplasms, growth-hormone-secreting-pituitary-adenoma, hyperplasia, instabilities-chromosomal, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, neoplasm-metastasis, neoplasms, pituitary-adenoma, pituitary-diseases, pituitary-neoplasms, tumor-angiogenesis, tumor-progression.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pituitary Tumor Transforming Gene Overexpression, and have been seen in publications frequently: Adrenal Gland Development, Angiogenesis, Cell Differentiation, Cell Motility, Cell Proliferation, Chromosome Separation, Dna Repair, Gland Development, Interphase, Mitosis, Pathogenesis, Replicative Senescence, Secretion, Senescence, Wound Healing

Quite a number of genes have been found to play important roles in Pituitary Tumor Transforming Gene Overexpression, such as AKT1, APC, ARHGAP1, DLK1, FOXA2, GGH, GH1, PBX1, PRL, PTK2B, PTTG1, RAF1, RHOG, ZHX2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.